Indian generic drug maker Sun Pharmaceutical Industries Ltd. (524715.BY) said Tuesday the U.S. drug regulator has allowed resumption of operations at unit Caraco Pharmaceutical Laboratories Ltd.'s manufacturing facility and packaging sites in Detriot and Wixom, Michigan. Caraco had to halt operations at Detriot and Wixom after the U.S. Food and Drug Administration found some drug-manufacturing defects in 2009. The FDA has allowed production of Carvedilol USP and Paramomycin USP drugs from these facilities, India's largest drug maker by market capitalization said in a statement.
